14-day Premium Trial Subscription Try For FreeTry Free
NYSE:CRXM
Delisted

Taxus Cardium Pharmaceuticals Group, Inc Stock Price (Quote)

$0.000001
+0 (+0%)
At Close: Nov 10, 2022

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Thursday, 10th Nov 2022 CRXM stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0001

Historical Taxus Cardium Pharmaceuticals Group, Inc prices

Date Open High Low Close Volume
Nov 10, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Nov 09, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Nov 08, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Nov 07, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Nov 04, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Nov 03, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Nov 02, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Nov 01, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 31, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 28, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 27, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 26, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 25, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 24, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 21, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 20, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 19, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 18, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 17, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 14, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 13, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 12, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 11, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 10, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Oct 07, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About Taxus Cardium Pharmaceuticals Group, Inc

Taxus Cardium Pharmaceuticals Group Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced ... CRXM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT